![Logo for AIM ImmunoTech Inc](/_next/image?url=https%3A%2F%2Ffiles.quartr.com%2Fcompany-logos%2F50458-2023-03-29-08-06-51.png&w=256&q=100)
AIM ImmunoTech Investor Relations Material
Latest events
![Logo for AIM ImmunoTech Inc](/_next/image?url=https%3A%2F%2Ffiles.quartr.com%2Fcompany-logos%2F50458-2023-03-29-08-06-51.png&w=128&q=100)
Q1 2024
AIM ImmunoTech
Access the full event backlog
Slides, Transcripts, and Reports from 9,000+ public companies
Latest reports from AIM ImmunoTech Inc
Access all reports
AIM ImmunoTech Inc., formerly known as Hemispherx Biopharma, Inc., is an immuno-pharmaceutical company dedicated to the research and development of therapeutics for the treatment of multiple types of cancers, viral diseases, and immune-deficiency disorders. The company's leading product candidate is Ampligen, a drug composed of macromolecular ribonucleic acid molecules aimed at treating chronic fatigue syndrome (CFS). Ampligen is also under development for various cancer types, including renal cell carcinoma, malignant melanoma, and others, as well as for conditions like Hepatitis B, HIV, COVID-19, and post-COVID conditions. Another key product is Alferon N Injection, an injectable formulation of natural alpha interferon for treating human papillomavirus (HPV) and genital warts. The company is headquartered in Ocala, Florida, and its shares are listed on the NYSE.
Key slides for AIM ImmunoTech Inc
![Pancreatic Cancer](/_next/image?url=https%3A%2F%2Fcdn.quartr.com%2Fimages%2Fconference-calls%2Faim-immunotech-inc-investor-presentation-da8cfd3ae8775a8a%2F10.png&w=3840&q=75)
![Logo for AIM ImmunoTech Inc](/_next/image?url=https%3A%2F%2Ffiles.quartr.com%2Fcompany-logos%2F50458-2023-03-29-08-06-51.png&w=128&q=100)
Investor Presentation
AIM ImmunoTech Inc
![Well - Developed Saf](/_next/image?url=https%3A%2F%2Fcdn.quartr.com%2Fimages%2Fconference-calls%2Faim-immunotech-inc-investor-presentation-da8cfd3ae8775a8a%2F6.png&w=3840&q=75)
![Logo for AIM ImmunoTech Inc](/_next/image?url=https%3A%2F%2Ffiles.quartr.com%2Fcompany-logos%2F50458-2023-03-29-08-06-51.png&w=128&q=100)
Investor Presentation
AIM ImmunoTech Inc
Latest articles
![Key](/_next/image?url=https%3A%2F%2Fa.storyblok.com%2Ff%2F182663%2F1882x1059%2F7e17876154%2Fbirkin.png&w=3840&q=75)
The Birkin Bag: The Story Behind the World's Most Desired Handbag
How the Birkin bag became the world's most sought-after handbag where even the wealthy must earn the right to own one.
12 Jul 2024
![Key](/_next/image?url=https%3A%2F%2Fa.storyblok.com%2Ff%2F182663%2F2688x1512%2F8365aa8316%2Ftop-10-largest-semiconductor-companies.png&w=3840&q=75)
The 10 Largest Semiconductor Companies in the World
Discover the top 10 semiconductor companies by market cap, exploring their innovations and business models shaping the tech landscape.
10 Jul 2024
![Key](/_next/image?url=https%3A%2F%2Fa.storyblok.com%2Ff%2F182663%2F2000x1125%2F135c0e3f6b%2Fthe-rise-of-nubank.png&w=3840&q=75)
The Rise of Nubank: Changing Latin American Finance
Discover how Nubank revolutionized Latin American banking with innovation, backed by top investors like Berkshire Hathaway.
9 Jul 2024
Ticker symbol
AIM
Country
🇺🇸 United States